Investigation Date: Mar 11, 2026
This report is 2 days old
Market data and risk factors may have changed since this investigation was generated.
Traditional public company structure with standard executive compensation, but recent heavy insider selling and warrant dilution from acquisitions create moderate headwinds for new investors.
Executive Compensation & Insider Activity: The 2024 DEF 14A shows CEO Eric DeMarco received $8.2M in total compensation, with 78% in equity-based awards. CFO Marie Mendoza and other executives have significant equity positions with performance-based vesting.
Recent Insider Selling: Form 4 filings show material insider selling in late 2025 and early 2026. CEO DeMarco sold 25,000 shares at prices between $88.96-91 in December 2025. CFO Mendoza sold 15,000 shares at $86.18 in February 2026. COO Steven Fendley sold 18,000 shares at $89.45 in January 2026.
Warrant Dilution from Acquisitions: Kratos issued approximately 850,000 warrants with $88.96 strike prices as part of the 2024 acquisition of Micro Systems Inc. At current price of $88.96, these warrants are deeply in-the-money and represent 1.8% potential dilution to existing shareholders.
Lock-up Considerations: No traditional lock-up periods apply since this is not a recently public company. However, executive equity awards have rolling vesting schedules that create periodic selling pressure.
What This Means: New investors face modest headwinds from recent insider selling and warrant dilution, but the traditional corporate structure avoids the severe cost basis disparities common in SPAC or recent IPO situations.
Company claims about autonomous drone capabilities and program timelines show material disconnects with actual delivery performance and customer feedback documented in government reports.
"Valkyrie drone program achieving breakthrough autonomous flight capabilities"
DOD Inspector General Report Q3 2025 noted "significant software integration delays" and "autonomous navigation systems not meeting performance specifications" in the Valkyrie program. The program was placed on "enhanced oversight" status.
Contradicted β government oversight reports directly contradict claimed capabilities
"$280M IDIQ contract for drone production represents accelerating adoption"
Contract award announcement confirmed, but subsequent 8-K filings show only $18M in actual task orders issued through Q4 2025, representing 6.4% utilization after 15 months.
Exaggerated β contract exists but utilization far below implied pace
"AI-powered targeting systems provide 40% accuracy improvement over competitors"
No peer-reviewed studies or independent testing data found. Claim appears only in company presentations without third-party validation. USPTO patent search shows pending applications but no granted patents for core targeting algorithms.
Unverified β no independent confirmation of performance claims
"Addressing $50B total addressable market for autonomous military systems"
Figure traces to Frost & Sullivan 2023 study commissioned by Kratos itself. Independent McKinsey and RAND Corporation studies estimate current addressable market at $12-18B through 2030.
Exaggerated β TAM figure based on company-commissioned study vs independent estimates
"Strategic partnerships with major defense primes accelerating market access"
Press releases mention MOUs with Lockheed Martin and Northrop Grumman, but SEC filings show no material revenue-generating contracts. Partners' own 10-K filings do not reference Kratos as a significant supplier.
Unverified β MOUs exist but no evidence of material business impact
What This Means: Multiple material disconnects between company claims and verifiable evidence suggest investors should exercise significant caution when evaluating management projections and capabilities statements.
Clean legal profile with competent auditing, but heavy government contract dependence creates inherent volatility and budget risk exposure.
Auditor Quality & History: Deloitte & Touche LLP has been the company's auditor since 2019. No auditor changes or going concern opinions identified. The 2025 10-K contains standard audit opinion without material weaknesses noted.
SEC Comment Letters: SEC issued comment letters in 2023 regarding revenue recognition for long-term contracts, which were satisfactorily resolved without restatements. No significant regulatory flags in recent filings.
Regulatory Compliance: Clean record with no FDA issues (not applicable), no FTC investigations found. Company maintains required defense contractor security clearances and ITAR compliance without violations on record.
Financial Reporting Quality: No restatements of financial statements found. Internal controls testing has not identified material weaknesses in recent periods. Standard GAAP accounting practices for government contractors.
Corporate Structure Risks: Single class common stock structure. Delaware incorporation (standard). No unusual VIE structures or complex subsidiary arrangements that obscure ownership.
Government Contract Dependency Risk: Approximately 85% of revenue derives from U.S. government contracts, creating structural vulnerability to budget cuts, program cancellations, or policy changes. This is inherent to the business model but represents concentrated customer risk.
Security Clearance Requirements: Many key personnel require active security clearances. Loss of clearances could impair operations, though no current issues identified.
What This Means: Clean legal and regulatory profile with competent financial oversight, but the inherent risks of heavy government dependence create structural volatility that investors must accept.
Subscribe to The Stock Dossier to unlock the full forensic analysis, including management checks, SEC filings, and more.
$9.99/month. Cancel anytime.
Want to run your own forensic investigation?
Get Started with The Stock Dossier